Stay updated on ONO-4538 in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the ONO-4538 in Gastric Cancer Clinical Trial page.

Latest updates to the ONO-4538 in Gastric Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to include new information about the ONO-4538 study for gastric cancer, specifically mentioning the drug Capecitabine and the revision number has changed from v2.14.4 to v2.15.0. However, significant details about the study's purpose and criteria have been removed.SummaryDifference9%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to ONO-4538 in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONO-4538 in Gastric Cancer Clinical Trial page.